Newsletters

8/1/2017
Imaging3 Announces Successful Conclusion of Mandatory Self-Remediation Period
7/31/2017
Imaging3 Announces Successful Conclusion of Mandatory Self-Remediation Period
6/20/2017
Imaging3 Engages Intertek to Assist with Hazard Analytic Requirements Relating to the 510(k) Application with the FDA
6/12/2017
Imaging3 Engages Med-Device Consulting, Inc. to Assist on 510(k) Application with the FDA
2/10/2017
Imaging3 Clarifies Announcement Concerning Closing of the Company’s Bankruptcy Proceeding
2/10/2017
Imaging3 Clarifies Announcement Concerning Closing of the Company’s Bankruptcy Proceeding
2/7/2017
Imaging3 Announces Closing of the Company’s Bankruptcy Proceeding
1/30/2017
Imaging3 and Greenberg Glusker Reach Agreement on Legal Fees
11/29/2016
Scott R. Pancoast Joins the Imaging3 Team
10/12/2016
Imaging3, Inc. (OTCQB: “IGNG”) Announces Execution of Consulting Service Agreement with Biologics Consulting Group, Inc.
9/14/2016
Imaging3, Inc. (OTCQB: “IGNG”) Announces execution of agreement with CriTech Research to Complete Software Verification, Validation and Remediation for the Company’s Planned FDA 510(k) Application
9/7/2016
Imaging3, Inc. Announces Commencement of Trading of its Common Stock on the OTCQB under Trading Symbol “IGNG”.
7/14/2016
Imaging3, Inc. announces it is now approved for trading.
11/24/2015
Imaging3, Inc. Announces 2012-2013, 2103-2014, 10K’s completed.
5/28/2015
Imaging3 Newsletter
2/6/2015
Imaging3, Inc. Announces 2015 Outlook and Updates
9/25/2014
Imaging3 Announces New Board of Directors Members